DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Vaidya Sane Ayurved Laboratories Limited?

Vaidya Sane Ayurved Laboratories Limited has a price-to-earnings (PE) ratio of 19.0 in the Healthcare sector.

What is the market capitalisation of Vaidya Sane Ayurved Laboratories Limited?

Vaidya Sane Ayurved Laboratories Limited has a market capitalisation of approximately ₹169 crore.

Is Vaidya Sane Ayurved Laboratories Limited a profitable company?

Vaidya Sane Ayurved Laboratories Limited generates a return on equity of 12.5% with a net profit margin of 8.4%. That is a reasonable return on shareholder capital.

What is the 52-week high and low of MADHAVBAUG?

Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG) has traded between ₹147 and ₹335 over the past 52 weeks, against a current price of ₹162.1.

Does Vaidya Sane Ayurved Laboratories Limited pay a dividend?

Yes. Vaidya Sane Ayurved Laboratories Limited currently offers a dividend yield of 0.31%. Dividend payments depend on the board's declaration each year.

Vaidya Sane Ayurved Laboratories Limited

₹162.10▼ -5.85 (-3.48%)

MADHAVBAUG·NSE·Healthcare

Market Cap

169.37 Cr

PE Ratio

18.96

Volume

1,600

Day High - Low

162.55 - 162.10

52W High-Low

335.00 - 147.00

₹162.10▼ -5.85 (-3.48%)

Market Cap169.37 Cr

PE Ratio18.96

Volume1,600

Day High - Low162.55 - 162.10

52W High-Low335.00 - 147.00

Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG): company summary

The company's business improved with annual revenue rising 18.8% and annual net profit rising 28.4%.

Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG) is a micro-cap Healthcare company valued at ₹169 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move: Vaidya Sane Ayurved Laboratories Limited last traded at ₹162.1, down 3.48% on the day.
Financial performance: The company's business improved with annual revenue rising 18.8% and annual net profit rising 28.4%. The latest quarter showed revenue up 18.8% and net profit up 33.3% compared to the same quarter a year earlier. Net profit margin increased by 0.6 percentage points to 8.4%, while return on equity remained at 12.5%.
Valuation multiples: The stock trades at 19.0 times earnings, a discount to the Healthcare median of 32.0, 1.91 times book value. It yields 0.3%.
Things to watch: The company's stock is 47.0% below its 52-week high. It is not paying out dividends despite repeated profits. The promoter holding is 66.34%, but there is no foreign or domestic institutional holding.
Where it stands: The company's stock is 47.0% below its 52-week high. The latest quarter net profit rose 33.3% compared to the same quarter a year earlier. The promoter holding is 66.34%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

5.1/10

Weak

Fair Value

ROE

12.54%

Average

P/E

18.96x

Fair

Debt / Equity

0.04

Low

Industry

Healthcare

Medical Equipment & Supplies

Overall View

Weak

Price performance

Day₹162.10

₹162.55

52W₹147.00

₹335.00

DocStoX take

Supported by risk (7.2) and growth (6.9), but held back by momentum (0.0).

DocStoX score

Low confidence

5.1

/10

Weak

Quality

Modest

ROE 12.5%

Valuation

Fair

P/E 19.0×

Growth

Steady

Revenue +2.6% 3Y CAGR

Risk

Moderate

D/E 0.04

Momentum

Weak

8% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹162

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹169 Cr

52W High / Low

₹335 / ₹147

Dividend Yield

0.31%

Promoter Holding

66.34%

EPS (TTM)

₹8.55

Book Value

₹7167.55

Key highlights

Low leverage — D/E 0.04
Profitable in all of the last 4 years
Profit compounding 22% a year
Momentum is weak (0.0/10)
Revenue barely growing (3% a year)

3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Medical Equipment & Supplies

Explore Vaidya Sane Ayurved Laboratories Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Vaidya Sane Ayurved Laboratories Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Vaidya Sane Ayurved Laboratories Limited with peers

Vaidya Sane Ayurved Laboratories Limited vs Sun Pharmaceutical Industries Limited Vaidya Sane Ayurved Laboratories Limited vs Divi's Laboratories Limited Vaidya Sane Ayurved Laboratories Limited vs Torrent Pharmaceuticals Limited Vaidya Sane Ayurved Laboratories Limited vs Apollo Hospitals Enterprise Limited Vaidya Sane Ayurved Laboratories Limited vs Zydus Lifesciences Limited Vaidya Sane Ayurved Laboratories Limited vs Laurus Labs Limited

Related tools & concepts

Value Vaidya Sane Ayurved Laboratories Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

MADHAVBAUG newsLatest coverage & filings Open screenerFilter the whole market